Weining Volinn

Rapid Efficacy of the Highly Selective α_1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies

Leonard S. Marks, Marc Gittelman, Lawrence A. Hill et al. · The Journal of Urology · 2012 · 161 citations

Medicine, Pharmacotherapy, Urology +12

Rapid Efficacy of the Highly Selective α_1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies

Leonard S. Marks, Marc Gittelman, Lawrence A. Hill et al. · The Journal of Urology · 2009 · 143 citations

Medicine, Pharmacotherapy, Urology +12

Silodosin in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia: A 9-Month, Open-label Extension Study

Leonard S. Marks, Marc Gittelman, Lawrence A. Hill et al. · Urology · 2009 · 66 citations

Medicine, Pharmacotherapy, Urology +6

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH

Claus G. Roehrborn, Steven A. Kaplan, Herbert Lepor et al. · Prostate Cancer and Prostatic Diseases · 2010 · 60 citations · Full text

Medicine, Pharmacotherapy, Urology +17

Lack of Pharmacodynamic Interaction of Silodosin, a Highly Selective α1a-Adrenoceptor Antagonist, With the Phosphodiesterase-5 Inhibitors Sildenafil and Tadalafil in Healthy Men

Scott MacDiarmid, Lawrence A. Hill, Weining Volinn et al. · Urology · 2010 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +13